Complexities in interpretation of osteosarcoma clinical trial results - Reply Journal Article

  

Authors:	Meyers, P. A.; Schwartz, C. L.; Krailo, M. D.; Healey, J. H.; Ferguson, W. S.; Gebhardt, M. C.; Goorin, A. M.; Kleinerman, E. S.; Nieder, M. L.; Wells, R. J.; Sato, J. K.; Grier, H. E.
Article Title:	Complexities in interpretation of osteosarcoma clinical trial results - Reply
Keywords:	osteosarcoma; cancer chemotherapy; cancer survival; overall survival; clinical trial; cisplatin; doxorubicin; treatment duration; disease free survival; methotrexate; drug megadose; gold standard; letter; clinical practice; multiple cycle treatment; autologous stem cell transplantation; ifosfamide; statistical significance; add on therapy; neuroblastoma; muramyl tripeptide; drug substitution
Journal Title:	Journal of Clinical Oncology
Volume:	26
Issue:	18
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2008-01-01
Start Page:	3104
End Page:	3105
Language:	English
DOI:	10.1200/jco.2008.17.2510
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-51349105815&partnerID=40&md5=e611129da456ec6590bb939f6c8087f8
Notes:	--- - "Cited By (since 1996): 2" - "Export Date: 17 November 2011" - "CODEN: JCOND" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/14943